TY - JOUR
T1 - Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break
AU - Shamseddeen, Wael
AU - Clarke, Gregory
AU - Wagner, Karen Dineen
AU - Ryan, Neal D.
AU - Birmaher, Boris
AU - Emslie, Graham
AU - Asarnow, Joan Rosenbaum
AU - Porta, Giovanna
AU - Mayes, Taryn
AU - Keller, Martin B.
AU - Brent, David A.
N1 - Funding Information:
Disclosure: Dr. Asarnow receives research grants from the National Institute of Mental Health . She has received honoraria from the California Institute of Mental Health, Hathaways-Sycamores, and the Melissa Institute. She has served as a consultant to Pfizer. She has received unrestricted funding Philip Morris. Dr. Wagner has received research support from NIMH, and has served on an advisory board for Forest. Dr. Birmaher has received research funding from NIMH. He has served as a consultant for Schering Plough. He has received royalties from Random House and Lippincott Williams and Wilkins. Dr. Emslie has received research support from Biobehaviorial Diagnostics, Eli Lilly and Co., Forest, GlaxoSmithKline, and Somerset. He has served as a consultant for Biobehaviorial Diagnostics, Eli Lilly and Co., GlaxoSmithKline, Pfizer, and Wyeth. Dr. Keller has served as a consultant and received honoraria from CENEREX, Medtronic, and Sierra Neuropharmaceuticals. He has received a grant from Pfizer . Dr. Brent has received research support from NIMH. He has received royalties from Guilford Press. He serves as editor for UpToDate Psychiatry. Drs. Shamseddeen, Clarke, and Ryan, and Ms. Porta, and Ms. Mayes report no biomedical financial interests or potential conflicts of interest.
Funding Information:
This work was supported by National Institute of Mental Health (NIMH) grants MH61835 (Pittsburgh); MH61856 (Galveston); MH61864 (UCLA); MH61869 (Portland); MH61958 (Dallas); and MH62014 (Brown), and MH66371 (Pittsburgh).
PY - 2011/11
Y1 - 2011/11
N2 - Objective: There is little work on the effect of school on response to treatment of depression, with available research suggesting that children and adolescents with school difficulties are less likely to respond to fluoxetine compared with those with no school difficulties. Method: Depressed adolescents in the Treatment of Resistant Depression in Adolescents study, who had not responded to a previous adequate selective serotonin reuptake inhibitor (SSRI) trial, were randomly assigned to one of the following: another SSRI, venlafaxine, another SSRI + cognitive behavior therapy (CBT), or venlafaxine + CBT. Participants were classified into four groups depending on whether their enrollment in the study and end of treatment was during school or summer vacation. Results: Controlling for baseline differences, adolescents ending their 12-week treatment during summer vacation had odds 1.7 times (95% confidence interval = 1.02-2.8, p = .04) greater to have an adequate response as those ending their treatment while being in school. In addition, adequate depression response was associated with fewer school problems at week 12 (scores <5 versus scores <5: odds ratio = 3.3, 95% confidence interval = 1.9-5.8, p < .001). There was a significant interaction between school difficulties and timing of treatment, with the lowest rates of response being among adolescents having school difficulties and ending their treatment during the active school year. Conclusion: School problems are relevant to treatment response in depressed adolescents and should be incorporated into the treatment plan. These findings also suggest that the time of the year might need to be taken into consideration for analysis of clinical trials in school-aged youth. Clinical trial registration information--Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://www.clinicaltrials.gov; NCT00018902.
AB - Objective: There is little work on the effect of school on response to treatment of depression, with available research suggesting that children and adolescents with school difficulties are less likely to respond to fluoxetine compared with those with no school difficulties. Method: Depressed adolescents in the Treatment of Resistant Depression in Adolescents study, who had not responded to a previous adequate selective serotonin reuptake inhibitor (SSRI) trial, were randomly assigned to one of the following: another SSRI, venlafaxine, another SSRI + cognitive behavior therapy (CBT), or venlafaxine + CBT. Participants were classified into four groups depending on whether their enrollment in the study and end of treatment was during school or summer vacation. Results: Controlling for baseline differences, adolescents ending their 12-week treatment during summer vacation had odds 1.7 times (95% confidence interval = 1.02-2.8, p = .04) greater to have an adequate response as those ending their treatment while being in school. In addition, adequate depression response was associated with fewer school problems at week 12 (scores <5 versus scores <5: odds ratio = 3.3, 95% confidence interval = 1.9-5.8, p < .001). There was a significant interaction between school difficulties and timing of treatment, with the lowest rates of response being among adolescents having school difficulties and ending their treatment during the active school year. Conclusion: School problems are relevant to treatment response in depressed adolescents and should be incorporated into the treatment plan. These findings also suggest that the time of the year might need to be taken into consideration for analysis of clinical trials in school-aged youth. Clinical trial registration information--Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://www.clinicaltrials.gov; NCT00018902.
KW - adolescent depression
KW - school problems
KW - therapy
KW - time variation
UR - http://www.scopus.com/inward/record.url?scp=80054862465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054862465&partnerID=8YFLogxK
U2 - 10.1016/j.jaac.2011.07.022
DO - 10.1016/j.jaac.2011.07.022
M3 - Article
C2 - 22024002
AN - SCOPUS:80054862465
SN - 0890-8567
VL - 50
SP - 1140
EP - 1148
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 11
ER -